HN
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.284
Exchange
XSTO - Nasdaq STOCKHOLM AB
0.7 B
Last period Cash and equivalents ,SEK
-8%
Cash and equivalents has decreased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Hansa Biopharma
Company Analysis
HNSA.ST valuation, rating, competitors, insights and company profile
Eyestock Rating
HNSA.ST financial analysis by Eyestock methodology
Valuation
HNSA.ST valuation using historical relative method
Statements
HNSA.ST Income Statements, Balance Sheet and Cash Flow Statements
Dividends
HNSA.ST dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Hansa Biopharma`s Cash and equivalents for the period ended 2024-06-30 are 0.7 B SEK
